Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-15446 · Session 1

Further to the answer to question S1W-15122 by Susan Deacon on 26 April 2001, why the information specified on people requiring prescriptio…

Answered Asked by Tricia Marwick SNP Lodged 27 Apr 2001

The question

To ask the Scottish Executive, further to the answer to question S1W-15122 by Susan Deacon on 26 April 2001, why the information specified on people requiring prescription of beta interferon is not available centrally and whether it plans to hold this information centrally.

The answer

Answered by Susan Deacon on 17 May 2001 · 20 days after it was lodged, 6 days after it was due

There are no plans to do so. Only certain patients with a diagnosis of multiple sclerosis are likely to benefit from the use of beta interferon and patients' eligibility for this treatment depends on the clinical judgement of the clinicians concerned. Clinical decisions regarding the treatment of individual patients are not available centrally.

In the Official Report

No contribution in the Official Report cites S1W-15446 by reference.